H2S SIBO And Celiac Disease Controversy: Doctors Disagree
- 01. What "H2S SIBO" claims to be
- 02. Why celiac enters the picture
- 03. Historical timeline of the debate
- 04. What's actually true vs commonly misunderstood
- 05. Key data points (illustrative, but realistic)
- 06. How to think about testing
- 07. Clinical decision checklist
- 08. Common myths driving the controversy
- 09. Illustrative patient pathway
- 10. Bottom line for readers
H2S-dominant SIBO is a proposed subtype of small intestinal bacterial overgrowth where sulfate-reducing bacteria (SRB) are thought to generate more hydrogen sulfide, and the "celiac controversy" centers on whether symptoms and test patterns are genuinely due to celiac disease or are being misattributed to celiac when the real driver is dysbiosis, overlapping gastrointestinal disorders, or false-positive/false-negative testing. In practice, the safest takeaway is that clinicians should not treat "H2S" as a stand-alone explanation for autoimmune disease risk, and people with celiac risk should still follow evidence-based celiac diagnostic pathways.
On the genetics-and-immunity side of celiac disease, the long-running debate is that elevated gastrointestinal fermentation markers (including breath gases) can mimic celiac-like symptoms, while celiac serology and intestinal biopsy reflect immune-mediated injury rather than fermentation chemistry alone. On the microbiology side of H2S SIBO, the debate is that breath H2S testing and symptom reports may point toward sulfate-reducing activity, but they cannot by themselves prove a specific disease mechanism or exclude autoimmune enteropathy.
For context, the "SIBO" concept entered mainstream gastroenterology decades ago, but interest in H2S as an additional breath-gas signal surged more recently as clinicians and researchers sought to refine "gas-pattern" phenotypes in breath testing. The celiac side has an even longer history: celiac diagnosis and monitoring became more standardized as serologic tests and histopathology criteria improved, yet diagnostic overlap with other causes of villous injury still exists. The upshot of this history is that today's diagnostic overlap can look like controversy even when it's mostly a problem of category errors (mixing symptom patterns with disease definitions).
What "H2S SIBO" claims to be
"H2S SIBO" is used in some clinical and consumer settings to describe a phenotype where hydrogen sulfide on breath testing is higher than expected, alongside symptoms such as diarrhea, bloating, abdominal discomfort, and sometimes a sulfur/"rotten egg" odor. The key controversy is that the term "SIBO" implies location (small intestine overgrowth) while hydrogen sulfide indicates a metabolic byproduct that could be influenced by multiple microbiome and host factors.
In other words, hydrogen sulfide is not a disease label-it's a molecule that can rise when sulfate-reducing microbes are metabolically active in certain environments. That makes the clinical leap from "more H2S" to "therefore it's H2S-dominant SIBO" understandable as a working hypothesis, but controversial if it's treated as definitive proof.
- Proposed mechanism: SRB generate hydrogen sulfide during sulfate metabolism in the gut.
- Clinical signal: breath tests may show a higher H2S component in some patients with diarrhea-predominant symptoms.
- Core limitation: H2S elevation can be affected by diet, transit time, colonic fermentation, and other conditions.
- Practical implication: therapy decisions based only on H2S risk missing other diagnoses.
Why celiac enters the picture
The "celiac controversy" becomes visible when people with persistent GI symptoms, iron deficiency, or chronic diarrhea pursue celiac testing and discover complicated results: borderline serology, negative blood tests despite symptoms, or temporary symptom improvement with interventions that change gut gases. A second pathway to confusion happens when a clinician focuses on fermentation patterns rather than confirming or excluding autoimmune enteropathy.
Autoimmune enteropathy is not the same as fermentative diarrhea. Celiac disease is driven by immune responses to gluten peptides in genetically susceptible people, which can cause villous atrophy and nutrient malabsorption. Meanwhile, SIBO-like syndromes (including proposed gas-pattern phenotypes such as H2S) can produce overlapping symptoms without causing the same immune-mediated intestinal damage.
Historical timeline of the debate
In the earlier era of SIBO, hydrogen and methane were the dominant breath-test gases discussed, and fewer clinicians paid attention to hydrogen sulfide. As breath-test technology and interpretive frameworks expanded, some providers started adding H2S as an extra "clue" to phenotyping patients with diarrhea and fermentation-like symptom complexes.
On the celiac side, diagnostic refinement generally progressed toward standardized serology and biopsy confirmation criteria, but real-world practice still faced the issue that other conditions can resemble celiac symptoms. By the time celiac diagnostics became widespread, clinicians had to handle an increasing number of people with partial, inconsistent, or overlapping signals-where gut microbiome-driven symptoms can muddy the waters.
- Phase 1: SIBO framed primarily around hydrogen/methane breath patterns.
- Phase 2: H2S measurement gains attention as SRB metabolic activity becomes a topic.
- Phase 3: Patients and clinicians increasingly treat "gas phenotypes" as actionable categories.
- Phase 4: Controversy intensifies when H2S findings are used to infer (or replace) celiac workups.
What's actually true vs commonly misunderstood
What's broadly true: H2S can be produced in the gut, can be measured in some breath-test protocols, and may correlate with certain diarrhea-predominant presentations in some studies and clinical reports. What's commonly misunderstood: that H2S "proves" SIBO as the primary cause, or that H2S can "rule out" celiac disease, because autoimmune disease definitions require immune markers and/or characteristic intestinal injury patterns.
Another accurate-but-misapplied concept is that overlapping disorders exist. People can have celiac disease and also have symptoms influenced by microbiome changes, motility, dietary adaptation, or coexisting functional bowel disorders-so the presence of one factor doesn't automatically negate the other. This is where overdiagnosis and "diagnostic substitution" can occur: a test signal gets used as a shortcut where a full diagnostic pathway is warranted.
Key data points (illustrative, but realistic)
The numbers below are plausible "real-world planning" estimates often seen in gastro clinics, but they should not be treated as definitive prevalence figures for any single population. They're included to show how the controversy might play out statistically when clinicians rely on partial signals rather than full celiac criteria.
| Scenario | What's Measured | Typical Risk of Misclassification | Why |
|---|---|---|---|
| GI symptoms + positive H2S breath signal | Hydrogen sulfide on breath | Medium (about 20-35%) | H2S can rise from SRB activity without proving autoimmune injury |
| GI symptoms + negative celiac serology | Blood antibodies (e.g., tTG/EMA-type tests) | Low-to-medium (about 5-20%) | Serology can be negative in early disease, low gluten intake, or select contexts |
| GI symptoms + biopsy-proven celiac | Histology consistent with celiac | Low (about 1-5%) | Autoimmune injury criteria anchor the diagnosis |
| GI symptoms + both findings | H2S breath signal + celiac confirmation | Low (about 0-10%) for "presence," but higher for "cause weighting" | Coexisting conditions can shape symptoms even when celiac is real |
Notice that the higher misclassification risk often comes from cause weighting: even if celiac is present, clinicians may over-attribute symptoms to H2S (or vice versa), leading to incomplete treatment plans. This is why the controversy persists-because the clinical question isn't just "is something abnormal?" but "what is driving the symptoms and the intestinal injury?"
How to think about testing
The practical approach is sequential and confirmatory: first establish whether celiac disease is present using standard immune-based and (when needed) histologic criteria, then evaluate whether additional factors such as microbiome-driven fermentation patterns, motility issues, or dietary intolerances are contributing to symptoms. If H2S testing is used, it should be treated as an adjunct clue, not a substitute for an autoimmune workup.
When people seek "H2S SIBO" explanations online, they often encounter a simpler narrative than clinical reality. In clinic, the best reasoning process looks more like diagnostic triangulation: symptom history, diet context, celiac testing status, and evidence of small intestinal involvement rather than a single breath-gas reading.
Clinical decision checklist
If you're using this controversy to guide real-world decisions, the most useful question is whether the plan reduces the risk of missed celiac disease while still addressing symptom drivers. The checklist below frames safe next steps for both patients and clinicians.
- Confirm whether the person is currently eating gluten consistently before celiac serology.
- Interpret H2S breath results as a clue about fermentation physiology, not as definitive autoimmune exclusion.
- Look for objective celiac-aligned markers (serology and, when indicated, biopsy/histology) rather than symptoms alone.
- Evaluate alternative causes of villous injury and chronic diarrhea when results are discordant.
- Address co-factors that amplify symptoms (dietary intolerances, motility, pancreatic/bile factors, and medication effects).
Common myths driving the controversy
One myth: "H2S SIBO explains everything, so celiac testing is unnecessary." Another myth: "If H2S is elevated, celiac is impossible." Both misunderstand the difference between biochemical byproducts and immune-mediated intestinal damage. The controversy persists because these myths create a fast, single-cause narrative where clinical reality often involves multiple overlapping conditions.
Single-cause narratives also encourage treatment shortcuts-such as focusing only on reducing gut gases or SRB activity-when the patient may still need gluten-based diagnostic assessment or careful monitoring. On the flip side, some people reject celiac workups because they find an alternative label online, even when evidence-based autoimmune evaluation is still indicated.
Illustrative patient pathway
Consider a hypothetical timeline: a person in Amsterdam experiences chronic bloating and diarrhea and undergoes a breath test where H2S appears disproportionately high. They read about H2S SIBO and immediately start targeted antimicrobials or diet changes, but later they discover their celiac serology was checked after reduced gluten intake, complicating interpretation. When they return for proper evaluation, clinicians treat the problem as two-track work: confirm or exclude celiac disease using appropriate conditions, then address H2S-associated fermentation patterns as a possible contributor to symptoms.
"The safest approach is to separate questions: whether celiac disease is present, and whether other gut processes are amplifying symptoms."
Bottom line for readers
H2S SIBO and celiac disease are sometimes discussed as competing explanations, but the more evidence-aligned view is that they are different categories of evidence-metabolic/phenotypic signaling versus immune-mediated diagnosis. The controversy mainly reflects how easily people (and sometimes clinicians) can confuse overlapping symptom patterns with definitive disease causality. The best path forward is to avoid replacing celiac diagnostic standards with H2S narratives, while still investigating microbiome and fermentation physiology as symptom modifiers.
celiac disease should be confirmed or ruled out using evidence-based criteria when risk is plausible, and hydrogen sulfide-if measured-should be treated as a clue that can guide adjunct evaluation and symptom management rather than as an autoimmune "answer key."
Helpful tips and tricks for H2s Sibo And Celiac Disease Controversy Doctors Disagree
Are H2S results proof of SIBO?
No. H2S breath testing (where used) may suggest sulfate-reducing activity and fermentation physiology, but it does not, by itself, fully prove small intestinal bacterial overgrowth or its clinical causality. H2S should be treated as a signal that prompts further evaluation, not as a stand-alone diagnosis.
Can H2S symptoms feel like celiac disease?
Yes, GI symptoms can overlap. Diarrhea, bloating, and abdominal discomfort can occur in many conditions, including celiac disease and SIBO-like syndromes, so symptom overlap alone cannot distinguish autoimmune injury from fermentative or motility-driven mechanisms.
Can celiac cause gut changes that raise H2S?
It can, indirectly. Gut inflammation, dietary changes after diagnosis attempts, and altered microbiome ecology can shift fermentation patterns, which might influence breath gas outputs. That means "H2S positivity" does not automatically mean "no celiac," and it also does not guarantee "only H2S SIBO."
What should come first in evaluation?
If celiac disease is a realistic possibility, evidence-based celiac testing should not be skipped. Only after celiac is appropriately assessed should clinicians evaluate additional overlapping contributors such as dysbiosis patterns, motility disorders, or breath-test phenotypes.